VORINOSTAT AND DECITABINE IN TREATING PATIENTS WITH ADVANCED SOLID TUMORS OR RELAPSED OR REFRACTORY NON-HODGKIN'S LYMPHOMA, ACUTE MYELOID LEUKEMIA, ACUTE LYMPHOCYTIC LEUKEMIA, OR CHRONIC MYELOGENOUS LEUKEMIA: